IQVIA and Pierre Fabre Pharmaceuticals Expand Relationship to Deploy IQVIA’s Orchestrated Customer Engagement
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Business Wire
Innovative Solution Connects Commercial Functions and Channels for Improved Customer Interactions DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, and Pierre Fabre Pharmaceuticals, a subsidiary of Pierre Fabre S.A. and the 2nd largest French private pharmaceutical group, today announced plans to implement IQVIA’s new commercial technology solution, Orchestrated Customer Engagement (OCE). The new offering, uniquely adapted for the life sciences industry, connects marketing, sales and other critical business functions, enabling all departments to collaborate more effectively and optimize customer interactions. Under the terms of this seven-year agreement, Pierre Fabre Pharmaceuticals will migrate all of its current CRM users to OCE, which Pier
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Cegedim Full year 2023 results: Revenue and recurring operating income both up [Yahoo! Finance]Yahoo! Finance
- BioFuse Medical Technologies Appoints Dr. David Battleman as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® [Yahoo! Finance]Yahoo! Finance
- Insiders At IQVIA Holdings Sold US$10m In Stock, Alluding To Potential Weakness [Yahoo! Finance]Yahoo! Finance
- Eli Lilly warns of temporary short supply of two insulin products [CNN]CNN
IQV
Earnings
- 2/14/24 - Beat
IQV
Sec Filings
- 3/4/24 - Form 4
- 3/4/24 - Form 4
- 3/1/24 - Form 144
- IQV's page on the SEC website